These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26019270)
41. Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein. Chaudhary V; Yuen KS; Chan JF; Chan CP; Wang PH; Cai JP; Zhang S; Liang M; Kok KH; Chan CP; Yuen KY; Jin DY J Virol; 2017 Jul; 91(14):. PubMed ID: 28468880 [TBL] [Abstract][Full Text] [Related]
42. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. Brzózka K; Finke S; Conzelmann KK J Virol; 2006 Mar; 80(6):2675-83. PubMed ID: 16501077 [TBL] [Abstract][Full Text] [Related]
44. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818 [TBL] [Abstract][Full Text] [Related]
45. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9. Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091 [TBL] [Abstract][Full Text] [Related]
46. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. Klampfer L; Huang J; Corner G; Mariadason J; Arango D; Sasazuki T; Shirasawa S; Augenlicht L J Biol Chem; 2003 Nov; 278(47):46278-87. PubMed ID: 12972432 [TBL] [Abstract][Full Text] [Related]
47. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Meyts I; Casanova JL Eur J Immunol; 2021 May; 51(5):1039-1061. PubMed ID: 33729549 [TBL] [Abstract][Full Text] [Related]
48. Counter-regulation mechanism of IL-4 and IFN-α signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex. Kim SH; Lee CE Eur J Immunol; 2011 Feb; 41(2):461-72. PubMed ID: 21268015 [TBL] [Abstract][Full Text] [Related]
51. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. Schaber JD; Fang H; Xu J; Grimley PM; Rui H Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833 [TBL] [Abstract][Full Text] [Related]
52. In search of a function for human type III interferons: insights from inherited and acquired deficits. Zhang Q; Kisand K; Feng Y; Rinchai D; Jouanguy E; Cobat A; Casanova JL; Zhang SY Curr Opin Immunol; 2024 Apr; 87():102427. PubMed ID: 38781720 [TBL] [Abstract][Full Text] [Related]
53. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. Wang J; Pham-Mitchell N; Schindler C; Campbell IL J Clin Invest; 2003 Aug; 112(4):535-43. PubMed ID: 12925694 [TBL] [Abstract][Full Text] [Related]
54. IL-4 suppresses dendritic cell response to type I interferons. Sriram U; Biswas C; Behrens EM; Dinnall JA; Shivers DK; Monestier M; Argon Y; Gallucci S J Immunol; 2007 Nov; 179(10):6446-55. PubMed ID: 17982033 [TBL] [Abstract][Full Text] [Related]
55. Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha. Claudinon J; Gonnord P; Beslard E; Marchetti M; Mitchell K; Boularan C; Johannes L; Eid P; Lamaze C J Biol Chem; 2009 Sep; 284(36):24328-40. PubMed ID: 19561067 [TBL] [Abstract][Full Text] [Related]
56. Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors. Govender U; Corre B; Bourdache Y; Pellegrini S; Michel F J Leukoc Biol; 2017 May; 101(5):1181-1190. PubMed ID: 28242623 [TBL] [Abstract][Full Text] [Related]
57. A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. Morrow AN; Schmeisser H; Tsuno T; Zoon KC J Immunol; 2011 Feb; 186(3):1685-93. PubMed ID: 21178011 [TBL] [Abstract][Full Text] [Related]
58. Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. Strobl B; Bubic I; Bruns U; Steinborn R; Lajko R; Kolbe T; Karaghiosoff M; Kalinke U; Jonjic S; Müller M J Immunol; 2005 Sep; 175(6):4000-8. PubMed ID: 16148148 [TBL] [Abstract][Full Text] [Related]
59. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway. Schiavoni G; Mauri C; Carlei D; Belardelli F; Pastoris MC; Proietti E J Immunol; 2004 Jul; 173(2):1266-75. PubMed ID: 15240719 [TBL] [Abstract][Full Text] [Related]
60. Seneca Valley virus 3C Song J; Guo Y; Wang D; Quan R; Wang J; Liu J J Virol; 2023 Oct; 97(10):e0072723. PubMed ID: 37819133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]